Researcher Unno from Pharmacology BU to Present a Poster at the 84th Annual Meeting of the Japanese Cancer Association
Our researcher, Satoko Unno from the Pharmacology Business …
Diverse Approaches to New Chemical Modalities -Challenging the Undruggable Targets beyond Conventional Small Molecule Drug Discovery-
In recent years, targeted drug discovery has become increasingly challenging, making it essential to explore optimal modalities beyond traditional small molecules to develop new drugs successfully.
LSX USA Congress 2025
Boston, MA
Nissan Chemical and Axcelead DDP Enter into Business Partnership to Support Drug Discovery Research for RNA Therapeutics
Tokyo and Kanagawa, Japan, July 18, 2025 — …
PRD Therapeutics Initiates First-in-Human Clinical Trial of SOAT2-Selective Inhibitor ‘PRD001’ — Axcelead DDP Provides Comprehensive Non-Clinical Development Support —
PRD Therapeutics, Inc. (“PRD Therapeutics”), a clinical stage …
Evaluation of oral exposure increase for poorly soluble compounds with dissolution-improving formulations
The 52nd Annual Meeting of the Japanese Society of Toxicology
Lab-in-the-Loop Hit Discovery: Unlocking ‘Undruggable’ Targets with AI-Powered Hit Identification Platform
The discovery of lead compounds for classical druggable targets has become increasingly efficient; however, the development of therapeutics targeting “undruggable” targets continues to face significant hurdles and unmet needs. One of the key challenges in the hit-finding stage is the difficulty in identifying initial hits and obtaining seed compounds that can serve as viable starting points for lead optimization.
Development of an Exploratory Renal Toxicity Prediction Method for Oligonucleotide Therapeutics Using Human Proximal Tubule Epithelial Cells
The 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan
Researcher Oki from Screening BU to Deliver an Oral Presentation at the 52nd Annual Workshop of the Japanese Society of Toxicology
Our researcher, Hideyuki Oki from the Screening Business …
Researcher Hamada from DMPK BU to Present a Poster at the 52nd Annual Meeting of the Japanese Society of Toxicology
Our researcher, Teruki Hamada from the DMPK Business …